[
  {
    "ts": null,
    "headline": "Positive phase III data gives Merck potential boost for blockbuster Keytruda in injection form",
    "summary": "Merck has filed for approval for a new drug that could buoy the bottom line from headwinds in recent months.",
    "url": "https://finnhub.io/api/news?id=9a76b7624f852d4208510bbb16618a6f4ce13ba24923f861b8a982bd6e3888ac",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1743087609,
      "headline": "Positive phase III data gives Merck potential boost for blockbuster Keytruda in injection form",
      "id": 133481387,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BMY",
      "source": "Yahoo",
      "summary": "Merck has filed for approval for a new drug that could buoy the bottom line from headwinds in recent months.",
      "url": "https://finnhub.io/api/news?id=9a76b7624f852d4208510bbb16618a6f4ce13ba24923f861b8a982bd6e3888ac"
    }
  },
  {
    "ts": null,
    "headline": "Arbutus Biopharma (ABUS) Reports Q4 Loss, Tops Revenue Estimates",
    "summary": "Arbutus (ABUS) delivered earnings and revenue surprises of 12.50% and 17.46%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?",
    "url": "https://finnhub.io/api/news?id=db1432d7932d26d156fe74b9eb5d49bd9aafce68c76bd7fabdf388e100852797",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1743079502,
      "headline": "Arbutus Biopharma (ABUS) Reports Q4 Loss, Tops Revenue Estimates",
      "id": 133481484,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BMY",
      "source": "Yahoo",
      "summary": "Arbutus (ABUS) delivered earnings and revenue surprises of 12.50% and 17.46%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?",
      "url": "https://finnhub.io/api/news?id=db1432d7932d26d156fe74b9eb5d49bd9aafce68c76bd7fabdf388e100852797"
    }
  },
  {
    "ts": null,
    "headline": "3 Deeply Discounted Dividend Stocks to Buy Today",
    "summary": "Want to buy a good dividend stock and secure a great price in the process?  Three stocks that are trading at attractive valuations right now that you may not want to overlook are Bristol Myers Squibb (NYSE: BMY), United Parcel Service (NYSE: UPS), and Dell Technologies (NYSE: DELL).  Pharmaceutical giant Bristol Myers Squibb is trading at a significant discount; you can buy the stock at a forward price-to-earnings (P/E) multiple of just 9, which is based on analysts' estimates.",
    "url": "https://finnhub.io/api/news?id=56ba12298c56028b4a65b37cf0d9732da1fa6f6aa9f3dca3eafd7233bb5c2d19",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1743077820,
      "headline": "3 Deeply Discounted Dividend Stocks to Buy Today",
      "id": 133468169,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BMY",
      "source": "Yahoo",
      "summary": "Want to buy a good dividend stock and secure a great price in the process?  Three stocks that are trading at attractive valuations right now that you may not want to overlook are Bristol Myers Squibb (NYSE: BMY), United Parcel Service (NYSE: UPS), and Dell Technologies (NYSE: DELL).  Pharmaceutical giant Bristol Myers Squibb is trading at a significant discount; you can buy the stock at a forward price-to-earnings (P/E) multiple of just 9, which is based on analysts' estimates.",
      "url": "https://finnhub.io/api/news?id=56ba12298c56028b4a65b37cf0d9732da1fa6f6aa9f3dca3eafd7233bb5c2d19"
    }
  },
  {
    "ts": null,
    "headline": "Trump Weighs Tariffs on Pharma in Ireland. What It Means for Amgen, Gilead.",
    "summary": "Trump Weighs Tariffs on Pharma in Ireland. What It Means for Amgen, Gilead.",
    "url": "https://finnhub.io/api/news?id=963858e4e1f3ef91c07929e71bcdd8933db7df8363b7703b9afa50320998706c",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1743070920,
      "headline": "Trump Weighs Tariffs on Pharma in Ireland. What It Means for Amgen, Gilead.",
      "id": 134148459,
      "image": "",
      "related": "BMY",
      "source": "MarketWatch",
      "summary": "Trump Weighs Tariffs on Pharma in Ireland. What It Means for Amgen, Gilead.",
      "url": "https://finnhub.io/api/news?id=963858e4e1f3ef91c07929e71bcdd8933db7df8363b7703b9afa50320998706c"
    }
  }
]